|
Q3 FY2024
As of Oct 31, 2023
|
Q2 FY2024
As of Jul 31, 2023
|
Q1 FY2024
As of Apr 30, 2023
|
Q4 FY2023
As of Jan 31, 2023
|
Q3 FY2023
As of Oct 31, 2022
|
Q2 FY2023
As of Jul 31, 2022
|
Q1 FY2023
As of Apr 30, 2022
|
Q4 FY2022
As of Jan 31, 2022
|
Q3 FY2022
As of Oct 31, 2021
|
Q2 FY2022
As of Jul 31, 2021
|
Q1 FY2022
As of Apr 30, 2021
|
Q4 FY2021
As of Jan 31, 2021
|
Q3 FY2021
As of Oct 31, 2020
|
Q2 FY2021
As of Jul 31, 2020
|
Q1 FY2021
As of Apr 30, 2020
|
Q4 FY2020
As of Jan 31, 2020
|
Q3 FY2020
As of Oct 31, 2019
|
Q2 FY2020
As of Jul 31, 2019
|
Q1 FY2020
As of Apr 30, 2019
|
Q4 FY2019
As of Jan 31, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investments, current | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Deferred commissions, current | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Investments, non-current | ||||||||||||||||||||
| Accounts receivable, non-current | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred commissions, non-current | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Deferred revenue, current | ||||||||||||||||||||
| Debt, current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Debt, non-current | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Deferred revenue, non-current | ||||||||||||||||||||
| Other liabilities, non-current | ||||||||||||||||||||
| Total non-current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Preferred stock: $0.001 par value; 20,000,000 shares authorized; no shares issued or outstanding at January 31, 2023 and January 31, 2022 | ||||||||||||||||||||
| Common stock: $0.001 par value; 1,000,000,000 shares authorized; 168,539,392 shares outstanding at October 31, 2023, and 164,833,781 shares outstanding at January 31, 2023 | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost: 6,756,702 shares at October 31, 2023 and 6,806,618 shares at January 31, 2023 | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' equity (deficit) | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
| Preferred stock, shares authorized | ||||||||||||||||||||
| Common stock, par value (in dollars per share) | ||||||||||||||||||||
| Common stock, shares authorized (in shares) | ||||||||||||||||||||
| Common stock, shares issued (in shares) | ||||||||||||||||||||
| Treasury stock, shares (in shares) |
Loading...
